<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04632355</url>
  </required_header>
  <id_info>
    <org_study_id>Covid19-Pain</org_study_id>
    <nct_id>NCT04632355</nct_id>
  </id_info>
  <brief_title>Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care</brief_title>
  <acronym>Covid19-Pain</acronym>
  <official_title>After the First and Second Wave in Italy: What Effects of Musculoskeletal Pain Did the Covid-19 in Patients Who Have Hospital Care?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Don Carlo Gnocchi Onlus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Don Carlo Gnocchi Onlus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Worldwide, the COVID-19 pandemic continues to grow. Although COVID-19 mainly affects the&#xD;
      lungs and internal organs, musculoskeletal injury from this disease was reported with the&#xD;
      presentation of marked elevation in creatine kinase and lactate dehydrogenase levels.&#xD;
      Patients with post-acute COVID-19 are considered patients with a post-intensive syndrome&#xD;
      (PICS) that results in loss of functional independence.&#xD;
&#xD;
      In the physical and rehabilitation medical field, various modalities with therapeutic&#xD;
      exercise can be used to manage pain by a physical therapist and psychiatrist.&#xD;
&#xD;
      Pain management is particularly important during the COVID-19 pandemic because of the reduced&#xD;
      accessibility to hospitals and medical resources.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The COVID-19 survivors with pain symptoms will participated. In this phase, a face-to-face&#xD;
      interview will be conducted to collecting all outcomes about pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Self-reported Version of the Leeds Assessment of Neuropathic Symptoms and Signs</measure>
    <time_frame>Baseline</time_frame>
    <description>the characterization of the pain. Total of 24. &gt; 11 neuropathic pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PainDETEC</measure>
    <time_frame>Baseline</time_frame>
    <description>the characterization of the pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>EuroQol-5D</measure>
    <time_frame>Baseline</time_frame>
    <description>To measure quality of life, grade ranging from 0 (the worst possible health status) to 100 (the best possible health status)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Hospital Anxiety and Depression Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>To measure psychological status. 0-7 = Normal; 8-10 = Borderline abnormal (borderline case), 11-21 = Abnormal (case)</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interview</intervention_name>
    <description>This interview will be conducted to collecting all outcomes about musculoskeletal pain in COVID-19 survivors</description>
    <other_name>COVID-19 survivors</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had been recovered from COVID-19 infection, that is, COVID-19 survivors after&#xD;
        hospitalization in the abovementioned Hospitals of Italy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Recovered from COVID-19 infection.&#xD;
&#xD;
          -  COVID-19 survivors after hospitalization.&#xD;
&#xD;
          -  Musculoskeletal pain.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants will be excluded also if they score greater than 6 points on the Beck&#xD;
             Depression Inventory (BDI) or more than 30 points in the State Trait Anxiety Inventory&#xD;
             (STAI), dementia and not Italian speaking due to the high level of language skills&#xD;
             required for questionnaires and quantitative sensory testing.&#xD;
&#xD;
          -  Psychiatric or neurological disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge H Villafañe</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Don Carlo Gnocchi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jorge H Villafañe, Ph.D</last_name>
    <phone>3395857563</phone>
    <email>mail@villafane.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jorge Hugo Villafañe</name>
      <address>
        <city>Milan</city>
        <zip>20121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Pedersini P, Corbellini C, Villafañe JH. Italian Physical Therapists' Response to the Novel COVID-19 Emergency. Phys Ther. 2020 Jul 19;100(7):1049-1051. doi: 10.1093/ptj/pzaa060.</citation>
    <PMID>32280973</PMID>
  </reference>
  <reference>
    <citation>Pancera S, Galeri S, Porta R, Pietta I, Bianchi LNC, Carrozza MC, Villafañe JH. Feasibility and Efficacy of the Pulmonary Rehabilitation Program in a Rehabilitation Center: CASE REPORT OF A YOUNG PATIENT DEVELOPING SEVERE COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME. J Cardiopulm Rehabil Prev. 2020 Jul;40(4):205-208. doi: 10.1097/HCR.0000000000000529. Review.</citation>
    <PMID>32609464</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 13, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Don Carlo Gnocchi Onlus</investigator_affiliation>
    <investigator_full_name>Jorge Hugo Villafañe, PhD</investigator_full_name>
    <investigator_title>Researcher</investigator_title>
  </responsible_party>
  <keyword>Covid19</keyword>
  <keyword>Pain</keyword>
  <keyword>musculoskeletal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

